DIVP vs. PJP ETF Comparison

Comparison of Cullen Enhanced Equity Income ETF (DIVP) to PowerShares Dynamic Pharmaceuticals (PJP)
DIVP

Cullen Enhanced Equity Income ETF

DIVP Description

DIVP invests in large- and mid-cap value stocks that generally have higher dividend yield than the average of the funds US benchmark. The fund identifies value stocks that have low price-to-earnings ratio with above-average earnings and dividend growth potential. Companies are screened using fundamental research. The fund may invest up to 30% in non-US companies in the form of ADRs. While the portfolio is not rebalanced systematically, weighting is roughly equal to avoid overweighting of individual securities. To generate additional income, the fund selectively writes covered call options with a target range of between 25-40%. However, the covered call overlay limits participation in potential gains if shares increase in value. The adviser may sell stocks that are no longer viewed as attractive based on growth potential, dividend yield, or price. As an actively managed ETF, the fund manager has full discretion to make buy, hold, or sell decisions at any time.

Grade (RS Rating)

Last Trade

$26.31

Average Daily Volume

1,461

Number of Holdings *

32

* may have additional holdings in another (foreign) market
PJP

PowerShares Dynamic Pharmaceuticals

PJP Description The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$86.68

Average Daily Volume

8,301

Number of Holdings *

25

* may have additional holdings in another (foreign) market
Performance
Period DIVP PJP
30 Days -1.04% -0.09%
60 Days -0.27% -3.01%
90 Days 4.23% 1.35%
12 Months 24.63%
2 Overlapping Holdings
Symbol Grade Weight in DIVP Weight in PJP Overlap
BMY A 3.93% 3.61% 3.61%
MRK F 3.26% 5.03% 3.26%
DIVP Overweight 30 Positions Relative to PJP
Symbol Grade Weight
CSCO B 4.24%
MDT B 4.05%
EOG D 3.98%
VICI D 3.91%
DUK C 3.77%
PM A 3.61%
PPL C 3.55%
CAG D 3.45%
VZ D 3.36%
CMCSA A 3.26%
CVX A 3.25%
KVUE B 3.21%
C A 3.17%
XOM C 3.14%
TFC C 3.13%
BAC B 3.05%
DOC C 3.04%
BAX F 3.03%
RTX C 2.96%
SYY D 2.94%
MO A 2.7%
IBM C 2.6%
DOW F 2.34%
JCI B 2.28%
JPM A 2.22%
TRV B 2.13%
GD C 2.04%
RIO B 1.95%
UPS C 1.78%
GPC F 1.69%
DIVP Underweight 23 Positions Relative to PJP
Symbol Grade Weight
ABBV A -5.75%
ABT A -5.66%
PFE D -5.53%
JNJ D -5.51%
AMGN C -5.4%
LLY F -4.96%
CORT B -4.47%
REGN F -4.29%
PCRX C -3.85%
GILD A -3.78%
AMPH A -3.46%
UTHR A -3.42%
LGND A -3.41%
INVA C -3.4%
VTRS B -3.36%
AMRX B -3.34%
PBH A -3.34%
SUPN B -3.3%
JAZZ D -3.25%
ANIP F -3.05%
GERN C -2.94%
BIIB F -2.94%
PRGO D -2.87%
Compare ETFs